Ertogrul, Rodi; Ogul, Hayri; Yahsi, Yusuf; Sakci, Zakir; Ozdemir, Mustafa; Kantarci, Mecit; Levent, Akin

Background Superior capsular folds and fold-like structures in the glenohumeral joint are potential sources of superior shoulder POS=12ptpain. Purpose To obtain detailed information about the arthrographic anatomy and morphology of superior capsular folds and fold-like structures. Material and Methods This study followed a retrospective design and involved 300 consecutive shoulder magnetic resonance (MR) images and MR arthrograms in two centers. The origins and insertions of the superior capsular folds and fold-like structures in the glenohumeral joints were carefully examined and documented. Four subtypes of extensions in the sagittal-oblique plane of the posterior synovial fold were identified from the MR arthrograms, according to their associations with the biceps tendon long head, superior glenoid notch, and supraspinatus tendon. Further, two morphological subtypes of superior synovial folds were identified: cord-shaped and fan-shaped. Results Superior capsular folds and fold-like structures in the shoulder joint were identified in 11 (4%) patients. Of these 11 superior capsular folds, 6 (54.5%) were then confirmed upon arthroscopy. The cord-shaped type was the most common MR arthrographic superior synovial fold and was detected in 8/11 (72.7%) patients. Type B was the most common form according to the course and insertion of the superior capsular fold (4/11 [37%] patients). Conclusion Superior capsular folds, probably normal capsular anatomical variants, tend to be present in the posterior portions of the superior shoulder joint capsule and are rarely seen in MR arthrograms. These anatomical variations tend to be symptomatic, especially in young individuals.

Gökten, Murat; Öcal, Osman; Sezer, Can; Zırh, Selim; Muftuoglu, Sevda; Öcal, Elif; Bilginer, Burcak; Arat, Anıl

Background: Neuroprotective agents are needed to reduce cerebral damage during surgical or neurointerventional procedures including stroke patients. Purpose: To evaluate if thiopental can be used as a neuroprotective agent when injected intra-arterially in a transient ischemia model. Material and Methods: In total, 24 rabbits were studied as four groups of six animals. Group 1 served as the control group. In group 2, transient ischemia was obtained by intracarotid administration of degradable starch microspheres (DSM). Group 3 was administered thiopental intra-arterially via the carotid artery. Group 4 (experimental group) received both thiopental and DSM intra-arterially. DSM and thiopental were administered through a microcatheter placed into the common carotid artery via the central ear artery access. After sacrifice, apoptotic cells in the cerebral tissues of the animals were evaluated in H&E and TUNEL stained slides. Results: There was a significant increase in the number of apoptotic glial or neuronal cells in group 2 compared to the control group and group 3. The mean number of both the apoptotic neuronal cells (6.8 ± 2.1 vs. 2.5 ± 1.3, P < 0.001) and the apoptotic glial cells (9.4 ± 3.1 vs. 4.6 ± 1.6, P < 0.001) were higher in group 2 compared to group 4. In addition, a higher level of neurological improvement was observed in group 4 compared to group 2 based on neurological assessment score. Conclusion: The intra-arterial administration of thiopental has a protective effect on both glial and neuronal cells during temporary cerebral ischemia in low doses.

Kizilgoz, Volkan; Kantarci, Mecit; Tonkaz, Gokhan; Levent, Akin; Ogul, Hayri

Magnetic resonance imaging (MRI) has been widely used as an advanced imaging modality to detect prostate cancer and indicate suspicious areas to guide biopsy procedures. The increasing number of prostate examinations with MRI has provided an opportunity to detect incidental lesions, and some might be very significant to elucidate patient symptoms or occult neoplastic process in the early stages. These incidental lesions might be located in the prostate gland, adjacent tissues, or organs around the prostate gland or out of the genitourinary system. The field of view of prostate MRI includes not only the prostate gland but also other critical pelvic organs in this specific anatomical region. Some of these incidental lesions might cause the same symptoms as prostate cancer and might explain the symptoms of the patient, and some might indicate early cancer stages located outside the prostate. Reporting these lesions might be life-saving by initiating early disease treatment. Awareness of the predicted locations of congenital anomalies would also be beneficial for the radiologists to mention these incidental findings.